Mari Ariyasu

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 3

Top Topics

Randomized Controlled Trial

Top Venues

Scientific reports

Infection and drug resistance

This page only lists publications with an associated author ORCID identifier.

Publications

Satoshi Iwata, Andrew J Pollard, Yukio Tada, Shinya Omoto, Risa Y Shibata, Kenji Igarashi, Takahiro Hasegawa, Mari Ariyasu, Takuhiro Sonoyama
A phase 3 randomized controlled trial of a COVID-19 recombinant vaccine S-268019-b versus ChAdOx1 nCoV-19 in Japanese adults. Scientific reports 14 (1) (2024)
Satoshi Iwata, Andrew J Pollard, Yukio Tada, Shinya Omoto, Risa Y Shibata, Kenji Igarashi, Takahiro Hasegawa, Mari Ariyasu, Takuhiro Sonoyama
A phase 3 randomized controlled trial of a COVID-19 recombinant vaccine S-268019-b versus ChAdOx1 nCoV-19 in Japanese adults. Scientific reports 14 (1) (2024)
Matteo Bassetti, Mari Ariyasu, Bruce Binkowitz, Tsutae Den Nagata, Roger M Echols, Yuko Matsunaga, Kiichiro Toyoizumi, Yohei Doi
Designing A Pathogen-Focused Study To Address The High Unmet Medical Need Represented By Carbapenem-Resistant Gram-Negative Pathogens - The International, Multicenter, Randomized, Open-Label, Phase 3 CREDIBLE-CR Study. Infection and drug resistance 12 (2019)